PI3K alpha Inhibitor INK1117

An orally bioavailable inhibitor of the class I phosphoinositide 3-kinase (PI3K) alpha isoform with potential antineoplastic activity. PI3K alpha inhibitor INK1117 selectively inhibits PI3K alpha kinase, including mutations of PIK3CA, in the PI3K/Akt/mTOR pathway, which may result in tumor cell apoptosis and growth inhibition in PI3K alpha-expressing tumor cells. By specifically targeting class I PI3K alpha, this agent may be more efficacious and less toxic than pan PI3K inhibitors. Dysregulation of the PI3K/Akt/mTOR pathway is frequently found in solid tumors and results in promoting tumor cell growth, survival, and resistance to chemotherapy and radiotherapy; PIK3CA, one of the most highly mutated oncogenes, encodes the p110-alpha catalytic subunit of the class I PI3K. (NCI Thesaurus)

YOU MAY ALSO LIKE

PI3K

A type of enzyme that transmits signals in cells and that helps control cell growth. Some tumors have higher-than-normal levels of…

PI3 wt Allele

Human PI3 wild-type allele is located in the vicinity of 20q13.12 and is approximately 2 kb in length. This allele, which encodes…

PI3 kinase

A type of enzyme that transmits signals in cells and that helps control cell growth. Some tumors have higher-than-normal levels of PI3…

PI3 Gene

This gene plays a role in the inhibition of elastase activity.

PI-88

A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called antiangiogenesis agents. …

PI Questionnaire Question

A question associated with the PI version 1 questionnaire.